EP3471780
MEÐFERÐ VIÐ AMD MEÐ NOTKUN Á AAV2 AFBRIGÐI MEÐ AFLIBERCEPTI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.6.2017EP published:
28.10.2020EP application number:
17814223.8
EP translation filed:
4.1.2021Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
15.6.2037Expiry date:
15.6.2026Next due date:
30.6.2026
Title:
TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
Timeline
Today
16.6.2017EP application
28.10.2020EP Publication
4.1.2021Translation submitted
15.1.2021Registration published
15.6.2026Expires
Owner
Name:
Adverum Biotechnologies, Inc.Address:
1035 O'Brien Drive Suite A, Menlo Park, California 94025, US
Inventor
Name:
BLUMENKRANZ, MarkAddress:
Menlo Park, CA 94025, US
Name:
GASMI, MehdiAddress:
Menlo Park, CA 94025, US
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201662351234 PDate:
16.6.2016Country:
US
Classification
Categories:
A61K 48/00, A61K 35/761, A61P 27/02, C12N 15/09
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 11.5.2021
Expires: 15.6.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 6.5.2022
Expires: 15.6.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 24.5.2023
Expires: 15.6.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.6.2024
Expires: 15.6.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 9
Paid: 10.6.2025
Expires: 15.6.2026
Payer: G.H. Sigurgeirsson ehf.